butylscopolammonium bromide has been researched along with metoclopramide in 19 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (metoclopramide) | Trials (metoclopramide) | Recent Studies (post-2010) (metoclopramide) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 5,044 | 1,216 | 623 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | metoclopramide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.383 | |
| Myeloperoxidase | Homo sapiens (human) | 0.35 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.721 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.8 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.127 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 7.8 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.675 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.383 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 7.8 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.2 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.88 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.63 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.6237 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Kawamura, I; Miyoshi, A; Suyama, T | 1 |
| Chojnacki, J; Dziekański, S; Szeszko, A; Tkaczewski, W | 1 |
| Fuchs, HF; Maeder, HU | 1 |
| Hegedüs, V; Mohammed, SH | 1 |
| Conrad, G; Schmidt, R | 1 |
| Harrison, D; Thomas, M; Thompson, DG; Wingate, DL | 1 |
| Magaribuchi, T; Nosaka, K; Takenaga, H; Tamaki, H | 1 |
| Burcharth, F; Jensen, LI; Miskowiak, J | 1 |
| Ahmed, LT; Chenntouf, M; Larbi, LO; Merouana, A; Nait, B; Souiah, N | 1 |
| Martín Carrasco, C; Palacios Garciá, R; Rodríguez Vázquez, M | 1 |
| García-Olmo, D; García-Olmo, DC; Lucas, FJ; Payá, J | 1 |
| Bruyneel, P; Cornil, P; De Smet, MC; Schrijvers, D; Tai-Apin, C; Vermorken, JB | 1 |
| Azuara, ML; Barcia, E; Negro, S; Reyes, R; Sánchez, Y | 1 |
| Ajaj, W; Debatin, JF; Goehde, SC; Holtmann, G; Lauenstein, T; Papanikolaou, N; Ruehm, SG | 1 |
| Froehlich, JM; Juli, CF; Patak, MA; von Weymarn, C; Wentz, KU; Zollikofer, CL | 1 |
| Kaminska, E; Leppert, W; Mikolajczak, P; Okulicz-Kozaryn, I; Szulc, M | 1 |
| Date, Y; Fujimura, Y; Inoue, H; Kihira, Y; Kojima, E; Kumagai, T; Narahara, N; Ogawa, S; Sato, E; Tsuruta, Y; Yoshitomi, H | 1 |
2 trial(s) available for butylscopolammonium bromide and metoclopramide
| Article | Year |
|---|---|
A double-blind comparative study of the inhibitory effect of intraduodenally administered hyoscine-N-butylbromide on human duodenal motility.
Topics: Adolescent; Adult; Butylscopolammonium Bromide; Clinical Trials as Topic; Depression, Chemical; Double-Blind Method; Duodenum; Female; Gastrointestinal Motility; Humans; Male; Metoclopramide; Middle Aged; Placebos; Scopolamine Derivatives | 1977 |
[A double-blind study of the analgesic efficacy in kidney colic of the combination of dipyrone and spasmolytic with ketorolac trometamol].
Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Butylscopolammonium Bromide; Colic; Dipyrone; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Ketorolac Tromethamine; Kidney Diseases; Male; Metoclopramide; Middle Aged; Tolmetin; Tromethamine | 1993 |
17 other study(ies) available for butylscopolammonium bromide and metoclopramide
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Combined administration of metoclopramide, scopolan and proacid in the treatment of chronic duodenal ulcer].
Topics: Adult; Aluminum; Aluminum Hydroxide; Butylscopolammonium Bromide; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Female; Glycine; Humans; Male; Metoclopramide; Middle Aged; Scopolamine Derivatives | 1978 |
[Pharmacoradiography of the gastro intestinal tract (author's transl)].
Topics: Atropine; Butylscopolammonium Bromide; Gastrointestinal Diseases; Gastrointestinal Motility; Glucagon; Humans; Metoclopramide; Morphine; Oxyphenonium; Parasympatholytics; Physostigmine; Propantheline; Radiography | 1976 |
Double contrast examination of the stomach. An improved technique.
Topics: Adolescent; Adult; Aged; Butylscopolammonium Bromide; Child; Contrast Media; Duodenum; Esophagus; Glucagon; Humans; Methods; Metoclopramide; Middle Aged; Premedication; Radiography; Stomach | 1977 |
[Comparative examinations of stomach and duodenum with the use of Buscolysin and Cerucal].
Topics: Ampulla of Vater; Butylscopolammonium Bromide; Cholestasis; Duodenal Diseases; Duodenal Ulcer; Humans; Methods; Metoclopramide; Postoperative Complications; Radiography; Scopolamine Derivatives; Stomach Diseases | 1976 |
Gastric emptying as a determinant of the oral glucose tolerance test.
Topics: Activity Cycles; Adult; Butylscopolammonium Bromide; Fasting; Female; Gastric Emptying; Gastrointestinal Motility; Glucose Tolerance Test; Humans; Male; Metoclopramide | 1982 |
[Effects of trimebutine maleate on the gastrointestinal motility in conscious dogs].
Topics: Animals; Benzoates; Butylscopolammonium Bromide; Dogs; Gastric Emptying; Gastrointestinal Motility; Injections, Intravenous; Male; Metoclopramide; Trimebutine | 1982 |
Effect of lower oesophageal sphincter on oesophageal varices. A portographic study.
Topics: Butylscopolammonium Bromide; Depression, Chemical; Esophageal and Gastric Varices; Esophagogastric Junction; Humans; Liver Cirrhosis; Metoclopramide; Portography; Pressure; Stimulation, Chemical | 1981 |
[Antispasmodics in obstetrics: myth or reality (author's transl)].
Topics: Butylscopolammonium Bromide; Clorazepate Dipotassium; Dipyrone; Double-Blind Method; Drug Combinations; Female; Meperidine; Metoclopramide; Parasympatholytics; Phloroglucinol; Pyrrolidonecarboxylic Acid; Uterine Contraction | 1982 |
The effects of the pharmacological manipulation of postoperative intestinal motility on colonic anastomoses. An experimental study in a rat model.
Topics: Anastomosis, Surgical; Animals; Butylscopolammonium Bromide; Colon; Female; Gastrointestinal Agents; Gastrointestinal Motility; Male; Metoclopramide; Multivariate Analysis; Postoperative Period; Prospective Studies; Random Allocation; Rats; Rats, Sprague-Dawley; Wound Healing | 1997 |
Determination of compatibility and stability of drugs used in palliative care.
Topics: Atropine; Butylscopolammonium Bromide; Drug Interactions; Drug Stability; Drug Therapy, Combination; Humans; Metoclopramide; Morphine; Palliative Care; Ranitidine; Terminal Care | 1998 |
Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Butylscopolammonium Bromide; Dexamethasone; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Infusion Pumps; Male; Metoclopramide; Midazolam; Middle Aged; Morphine; Neoplasms; Palliative Care; Spain; Tramadol; Treatment Outcome | 2002 |
Real-time high-resolution MRI for the assessment of gastric motility: pre- and postpharmacological stimuli.
Topics: Adult; Butylscopolammonium Bromide; Contrast Media; Energy Intake; Female; Gadolinium DTPA; Gastrointestinal Motility; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Metoclopramide; Signal Processing, Computer-Assisted; Stomach | 2004 |
Small bowel motility assessment with magnetic resonance imaging.
Topics: Adolescent; Adult; Butylscopolammonium Bromide; Feasibility Studies; Female; Humans; Intestine, Small; Magnetic Resonance Imaging; Male; Metoclopramide; Middle Aged; Muscarinic Antagonists; Peristalsis | 2005 |
Analgesic effects of morphine in combination with adjuvant drugs in rats.
Topics: Adjuvants, Pharmaceutic; Analgesics, Opioid; Animals; Butylscopolammonium Bromide; Drug Interactions; Drug Therapy, Combination; Haloperidol; Male; Methotrimeprazine; Metoclopramide; Midazolam; Morphine; Pain; Rats, Wistar | 2014 |
[Stability of Six Drugs in Total Parenteral Nutrition Solution].
Topics: Betamethasone; Bromhexine; Butylscopolammonium Bromide; Drug Packaging; Drug Stability; Famotidine; Furosemide; Metoclopramide; Parenteral Nutrition Solutions; Parenteral Nutrition, Home Total | 2021 |